Prospect Biosystems engages in the development, manufacture, and marketing of bioanalytical instrumentation, reagents and a broad-range of biomarker applications to accelerate life sciences research; pharmaceutical development; clinical diagnostics; and surgical pathology.
Prospect’s EdgeTM Technology and its EDGE*TEST™ algorithm allow scientists, researchers, medical experts, including physicians and surgeons, involved in: